Pharmaceuticals, Biotechnology and Life Sciences
— On track to report pivotal complete response data by mid-4Q 2024 — CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical…
LOUISVILLE, Colo.–(BUSINESS WIRE)–Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung diseases, today announced that…
VRG50635 is one of the first drugs to enter clinical trials that was entirely discovered and developed using an AI-enabled…
LONDON–(BUSINESS WIRE)–Regulatory News: BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma…
SEONGNAM-SI, South Korea–(BUSINESS WIRE)–AriBio Co., Ltd. (AriBio), announces signing of exclusive marketing rights for AR1001, an investigational drug for early…
BOSTON–(BUSINESS WIRE)–The Harvard Undergraduate Venture Capital Group (VCG) will hold its annual Entrepreneurship Summit on Sunday, March 24, 2024, from…
SAN DIEGO–(BUSINESS WIRE)–#biotechnews–Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on…
Dr. Smith has participated in every MAIA funding round CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA,” the “Company”), a…
DUBLIN–(BUSINESS WIRE)–The “2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report” has been added to ResearchAndMarkets.com’s offering. The biopharmaceutical…
Efforts to reduce operational expenses confirming the cash runway until the end of April 2024 Mobilization of resources aimed at…